Does the lowest dose of Wegovy actually do anything?

Step 1: what the 0.25 mg dose is actually for

When semaglutide enters the body, it slows gastric emptying and signals to the brain that you're full. Those effects are real at 0.25 mg, but they're also the reason nausea and indigestion are common early on. The first dose isn't calibrated for maximum effect; it's calibrated for tolerance. Think of it as giving your GI tract a few weeks to settle before the prescriber moves you up. The NHS medicines information for semaglutide explains the schedule clearly, and it's worth reading before your first pen arrives.

Some people do notice a quieter appetite even at this stage. Others feel little different. Both experiences are normal. What matters is reaching the maintenance dose without side effects forcing you to stop, which is exactly what the slow start is designed to prevent. Rushing through or skipping a rung is something to discuss with your prescriber, never a self-directed decision.

If you want a plain overview of the full dose ladder, the Wegovy dose guide on this site runs through each step and what to expect at each level.

Step 2: what the evidence actually shows, and at which dose

The headline figures people quote (roughly 15% average body-weight reduction) come from the STEP 1 trial, a 68-week study in adults with obesity who reached the 2.4 mg weekly maintenance dose. That trial, published in the New England Journal of Medicine, didn't measure the effect of 0.25 mg in isolation: participants moved through the full schedule and results reflect the whole treatment period at therapeutic doses.

So no, the lowest dose alone won't replicate those numbers. It's the starting point of a process, not the process itself. A helpful analogy: the first week of a physiotherapy programme rarely restores full movement, it prepares the tissue for the work ahead. The first Wegovy pen is no different in principle.

For people curious about how the 0.25 mg pen compares with what they'll eventually be taking, if you're asking what the lowest dose of Wegovy is and how it sits alongside the higher steps, there's more detail on what the lowest Wegovy dose involves day to day.

Step 3: how long you stay at 0.25 mg, and what comes next

The standard titration schedule runs in approximately four-week steps: 0.25 mg, then 0.5 mg, then 1.0 mg, then 1.7 mg, then the 2.4 mg maintenance dose. That means the earliest most people reach maintenance is around month five. For some, the prescriber may slow that progression further if side effects are significant, and that's clinically sensible, not a setback.

A question the team at our clinical team hears regularly: "Can I just stay at 0.25 mg to avoid side effects?" The short answer is that some patients do remain at a lower dose than 2.4 mg if that's where they tolerate well and are still making progress, but that's an individual clinical judgement. If you're wondering what the lowest dose of Wegovy actually is and how it fits into the broader schedule, that's a good place to start before your first consultation. The page on staying at Wegovy's lowest dose covers the evidence around that decision in more detail.

One practical note: if you order by midday Monday to Friday and your prescription is approved, the pen goes out the same day with tracked next-working-day delivery. So the schedule stays on track without the wait disrupting your titration timing, something patients who've transferred from other providers often mention when they move to Wegovy through nume.

Side effects at 0.25 mg: usually the mildest point in the journey

Because the starting dose is low, most people find side effects are most manageable right here. Nausea, loose stools, constipation and indigestion are all part of the known GI profile of semaglutide (detailed on the NHS semaglutide medicines page) and they tend to peak after a dose increase, not at the outset.

That doesn't mean 0.25 mg is side-effect-free. A small proportion of people find even the first pen causes enough nausea to be disruptive. Staying well hydrated, eating smaller portions and avoiding fatty food in the first few days all help. If symptoms are severe or persistent (particularly any severe stomach pain that radiates to the back) seek medical advice promptly. Those symptoms need clinical assessment, not a wait-and-see approach.

Curious about the broader treatment picture before committing? The weight-loss treatment overview on this site sets out what the full journey typically looks like, and the FAQs page covers the questions people most commonly bring to their first consultation.